News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,561 Results
Type
Article (2455)
Company Profile (40)
Press Release (36066)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14188)
Career Advice (77)
Deals (2108)
Drug Delivery (9)
Drug Development (4188)
Employer Resources (10)
FDA (445)
Job Trends (768)
News (20319)
Policy (1068)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (147)
Allergies (6)
Alliances (3494)
ALS (4)
Alzheimer's disease (45)
Antibody-drug conjugate (ADC) (14)
Approvals (446)
Artificial intelligence (11)
Autoimmune disease (3)
Automation (1)
Bankruptcy (12)
Best Places to Work (478)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (29)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (19)
Cancer (138)
Cardiovascular disease (5)
Career advice (64)
Career pathing (1)
CAR-T (15)
Cell therapy (44)
Cervical cancer (2)
Clinical research (3255)
Collaboration (94)
Compensation (48)
COVID-19 (182)
CRISPR (7)
C-suite (27)
Cystic fibrosis (2)
Data (114)
Denatured (3)
Depression (3)
Diabetes (10)
Diagnostics (464)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4261)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6076)
Executive appointments (97)
FDA (492)
Featured Employer (3)
Funding (77)
Gene editing (14)
Gene therapy (18)
GLP-1 (60)
Government (149)
Healthcare (705)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (16)
Indications (2)
Infectious disease (187)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (1009)
IRA (7)
Job creations (292)
Job search strategy (62)
Kidney cancer (4)
Labor market (4)
Layoffs (38)
Leadership (1)
Legal (215)
Liver cancer (5)
Lung cancer (15)
Lymphoma (3)
Management (4)
Manufacturing (20)
MASH (4)
Medical device (309)
Medtech (309)
Mergers & acquisitions (1168)
Metabolic disorders (34)
Multiple sclerosis (7)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (90)
NextGen: Class of 2025 (355)
Non-profit (153)
Northern California (363)
Now hiring (4)
Obesity (16)
Opinion (15)
Ovarian cancer (10)
Pain (9)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (2)
Patents (22)
Patient recruitment (4)
Peanut (1)
People (5675)
Pharmaceutical (6)
Phase I (1388)
Phase II (1642)
Phase III (870)
Pipeline (76)
Policy (12)
Postmarket research (32)
Preclinical (596)
Press Release (2)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (12)
Rare diseases (22)
Real estate (423)
Recruiting (5)
Regulatory (817)
Reports (6)
Research institute (144)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (25)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Southern California (354)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (490)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1741)
Vaccines (28)
Venture capitalists (8)
Weight loss (12)
Women's health (1)
Worklife (1)
Date
Last 7 days (49)
Last 30 days (203)
Last 365 days (2576)
2025 (750)
2024 (2633)
2023 (2874)
2022 (3783)
2021 (4080)
2020 (3497)
2019 (2092)
2018 (1565)
2017 (1805)
2016 (1635)
2015 (1852)
2014 (1381)
2013 (1208)
2012 (1416)
2011 (1347)
2010 (1185)
Location
Africa (43)
Alabama (1)
Arizona (14)
Asia (1866)
Australia (298)
California (835)
Canada (143)
China (38)
Colorado (20)
Connecticut (10)
Delaware (4)
Europe (3850)
Florida (44)
Georgia (5)
Idaho (3)
Illinois (14)
India (1)
Indiana (32)
Japan (7)
Kansas (12)
Maryland (25)
Massachusetts (301)
Michigan (8)
Minnesota (14)
Missouri (3)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (69)
New York (49)
North Carolina (90)
Northern California (363)
Ohio (25)
Oklahoma (2)
Oregon (4)
Pennsylvania (49)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (354)
Tennessee (2)
Texas (72)
Utah (2)
Virginia (6)
Washington D.C. (1)
Washington State (58)
Wisconsin (6)
38,561 Results for "orca biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Orca Bio Announces Positive Results from the Pivotal Phase 3 Study of Investigational Orca-T® Compared to Allogeneic Stem Cell Transplant for the Treatment of Hematologic Malignancies
March 17, 2025
·
6 min read
Press Releases
Orca Bio’s Orca-T® Meets Primary Endpoint in the Pivotal Precision-T Phase 3 Clinical Study for Hematologic Malignancies
February 10, 2025
·
4 min read
Drug Development
Orca Bio Announces Completion of Patient Enrollment for the Precision-T Phase 3 Study of Orca-T
Orca Bio today announced that it has completed enrollment in the pivotal Precision-T Phase 3 clinical study.
June 5, 2024
·
3 min read
Press Releases
Orca Bio Presents Three-Year Survival Data with Orca-T® in Patients with Hematological Malignancies at the 66th ASH Annual Meeting
December 9, 2024
·
6 min read
Press Releases
Orca Bio Presents Clinical Results on Use of Orca-Q® without GvHD Prophylaxis in Patients with Hematological Malignancies at the 66th ASH Annual Meeting
December 9, 2024
·
3 min read
Biotech Bay
Orca Bio to Present Positive Clinical Data on Orca-T at the 50th Annual Meeting of the EBMT
Orca Bio today announced new data will be presented during the 50th Annual Meeting of the EBMT in Glasgow, United Kingdom.
April 11, 2024
·
4 min read
Biotech Bay
Orca Bio to Present Positive Clinical Outcomes with Orca-T in Patients with AML at 2024 ASCO Annual Meeting
Orca Bio, a biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced it will present new data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, from May 31–June 4.
May 23, 2024
·
4 min read
Press Releases
Orca Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 7, 2025
·
1 min read
Press Releases
Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial
February 10, 2025
·
8 min read
Biotech Bay
Orca Bio Presents Promising Data on Orca-T in Two Oral Presentations at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
Orca Bio today announced positive data on its lead investigational high-precision cell therapy, Orca-T, presented at the 2024 Tandem Meetings, Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood and Marrow Transplant Research (CIBMTR).
February 23, 2024
·
5 min read
1 of 3,857
Next
